Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Spicer

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Anti-Cancer Drug Design|November 22, 2001
Synthesis of tetracyclic benzodioxins as potential antitumour agentsJ A Spicer, W A Denny
Journal of Nuclear Medicine Technology|June 3, 1999
The effects of selected antineoplastic agents on the labeling of erythrocytes with technetium-99m using the UltraTag RBC kitJ A Spicer, W B Hladik, W E Mulberry
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1985
Adverse allergic reaction to technetium-99m methylene diphosphonateJ A Spicer, D F Preston, R L Stephens
Seminars in Nuclear Medicine|January 1, 1992
Radionuclide therapy of intractable bone pain: emphasis on strontium-89R G Robinson, D F Preston, J A Spicer, et al.
Seminars in Oncology|June 1, 1993
Clinical experience with strontium-89 in prostatic and breast cancer patientsR G Robinson, D F Preston, K G Baxter, et al.
The American Journal of Gastroenterology|October 1, 1983
The effect of food consistency on iron absorptionB S Skikne, S R Lynch, R G Robinson, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1987
Treatment of metastatic bone pain with strontium-89R G Robinson, J A Spicer, D F Preston, et al.
American Journal of Obstetrics and Gynecology|December 1, 1991
Prolonged clearance of intraperitoneal 16 alpha-[125I]iodo-17 beta-estradiol in presence of ascitesA Scharl, S Kullander, M W Beckmann, et al.
Anti-Cancer Drug Design|June 11, 1999
5,7-Disubstituted analogues of the mixed topoisomerase I/II poison N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA): DNA binding and patterns of cytotoxicityJ A Spicer, G J Finlay, B C Baguley, et al.
Journal of Medicinal Chemistry|June 6, 1997
Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamideJ A Spicer, S A Gamage, G J Atwell, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drug Design|November 22, 2001
Synthesis of tetracyclic benzodioxins as potential antitumour agentsJ A Spicer, W A Denny
Journal of Nuclear Medicine Technology|June 3, 1999
The effects of selected antineoplastic agents on the labeling of erythrocytes with technetium-99m using the UltraTag RBC kitJ A Spicer, W B Hladik, W E Mulberry
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1985
Adverse allergic reaction to technetium-99m methylene diphosphonateJ A Spicer, D F Preston, R L Stephens
Seminars in Nuclear Medicine|January 1, 1992
Radionuclide therapy of intractable bone pain: emphasis on strontium-89R G Robinson, D F Preston, J A Spicer, et al.
Seminars in Oncology|June 1, 1993
Clinical experience with strontium-89 in prostatic and breast cancer patientsR G Robinson, D F Preston, K G Baxter, et al.
The American Journal of Gastroenterology|October 1, 1983
The effect of food consistency on iron absorptionB S Skikne, S R Lynch, R G Robinson, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1987
Treatment of metastatic bone pain with strontium-89R G Robinson, J A Spicer, D F Preston, et al.
American Journal of Obstetrics and Gynecology|December 1, 1991
Prolonged clearance of intraperitoneal 16 alpha-[125I]iodo-17 beta-estradiol in presence of ascitesA Scharl, S Kullander, M W Beckmann, et al.
Anti-Cancer Drug Design|June 11, 1999
5,7-Disubstituted analogues of the mixed topoisomerase I/II poison N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA): DNA binding and patterns of cytotoxicityJ A Spicer, G J Finlay, B C Baguley, et al.
Journal of Medicinal Chemistry|June 6, 1997
Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamideJ A Spicer, S A Gamage, G J Atwell, et al.
Pageof 2